检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵宏丽[1] 王学谦[2] 张玉环[1] 孙晓慧[1]
机构地区:[1]天津市长征医院检测中心,300021 [2]天津医院
出 处:《中华检验医学杂志》2004年第6期359-361,共3页Chinese Journal of Laboratory Medicine
摘 要:目的 寻找特应性皮炎 (AD)患者易感的人白细胞抗原 (HLA)基因型 ,分析该易感基因的单链构象多态性与正常人的差别。方法 用序列特异性引物聚合酶链反应 (PCR SSP)检测 12 2例AD患者和 80名健康献血员的HLA DRB等位基因型 ,并分析该易感基因的单链构象多态性。结果 外源性AD组和AD合并哮喘及变应性鼻炎组HLA DR3 与正常对照组比较 ,基因频率升高 (RR =5 2 7和3 5 9,均P <0 0 5 ) ,而HLA DR6基因频率降低 (RR =0 10和 0 ,均P <0 0 5 ) ,而HLA DR3 阳性的 16例AD患者中 ,仅 1例的单链构象多态性与正常人不同。结论HLA DR6是AD的抗性基因 ,携带有HLA DR6的个体较不易患AD ,而HLA DR3 是易感基因 ,携带有HLA DR3 的个体 ,较易患AD ,而携带HLA DR3Objective To look for susceptible and resistant HLA gene of Atopic Dermatitis(AD), analyze single strand conformation polymorphism of the susceptible gene and observe whether the base sequence was different from healthy Method Polymerase chain reaction sequence specific primer(PCR SSP)was used to classify the HLA DRB allele of 122 patients and 80 controls PCR single strand conformation polymorphism(SSCP) was used to analyse the susceptible gene Results The DR 3 frequency of extrinic type of “pure” AD(EAD)group and complicated group was higher than that of the control group ( RR =5 27 and 3 59 respectively P <0 05) DR 6 frequency was lower than that of the control ( RR = 0 10and 0 respectively, P <0 05) There was no significance between instrinic type of “pure” AD(IAD) and control In 16 patients who were HLA DR 3 positive, there was only one patient had SSCP band type different from controls ( P >0 05). Conclusion HLA DR 3 was the susceptible gene of AD, while HLA DR 6 was the resistant gene of AD It indicated that people with HLA DR 3 were reliable to AD, while people with HLA DR 6 were not But there was no base difference between these people and the healthy in HLA DR 3
关 键 词:人白细胞抗原-DRB 基因多态性 特应性皮炎 易感性 相关性
分 类 号:R758.6[医药卫生—皮肤病学与性病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229